Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

BACKGROUND: Identifying and reducing cardiometabolic risks driven by obesity remains a healthcare challenge. The metabolic syndrome is associated with abdominal obesity and inflammation and is predictive of long-term risk of developing type 2 diabetes and cardiovascular disease in otherwise healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandsdal, Rasmus M., Juhl, Christian R., Jensen, Simon B. K., Lundgren, Julie R., Janus, Charlotte, Blond, Martin B., Rosenkilde, Mads, Bogh, Adrian F., Gliemann, Lasse, Jensen, Jens-Erik B., Antoniades, Charalambos, Stallknecht, Bente M., Holst, Jens J., Madsbad, Sten, Torekov, Signe S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960425/
https://www.ncbi.nlm.nih.gov/pubmed/36841762
http://dx.doi.org/10.1186/s12933-023-01765-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960425/
https://www.ncbi.nlm.nih.gov/pubmed/36841762
http://dx.doi.org/10.1186/s12933-023-01765-z

Ejemplares similares